Dr. Stephen L. Tam, MD
Internal Medicine (Internal Medicine Physician)
5380 S Rainbow, #110
Las Vegas, NV 89118
Who else practices at this address →
Clark County includes primary care (9% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 25
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 248
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Internal Medicine Physician primary
NV license 12069
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Vegas Valley Primary Care (7 clinicians)
- Mind Power Behavioral Services LLC (4 clinicians)
- 1st Clark County Medical Clinic LLC (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 248
- Services billed
- 14,074
- Patients’ average age
- 66
| Service | Times | Patients |
|---|---|---|
| Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | 2,251 | 120 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | 609 | 79 |
| Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | 442 | 39 |
| Application of electrical stimulation with therapist present, each 15 minutes | 442 | 39 |
| Biofeedback training | 215 | 15 |
| Application of blood vessel compression device | 156 | 25 |
| Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 145 | 112 |
| Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | 137 | 15 |
| Therapy procedure using manual technique, each 15 minutes | 133 | 15 |
| Training for self-care or home management, each 15 minutes | 132 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Lisinopril Other prescribers in Las Vegas, NV | 31 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Las Vegas, NV | 30 |
| Gabapentin Other prescribers in Las Vegas, NV | 27 |
| Atorvastatin Calcium Other prescribers in Las Vegas, NV | 19 |
| Ibuprofen Other prescribers in Las Vegas, NV | 14 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Las Vegas, NV | 14 |
| Furosemide Other prescribers in Las Vegas, NV | 14 |
| Trazodone Hcl Other prescribers in Las Vegas, NV | 14 |
| Montelukast Sodium Other prescribers in Las Vegas, NV | 13 |
| Pantoprazole Sodium Other prescribers in Las Vegas, NV | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $219 in total to this clinician.
| E.r. Squibb & Sons, L.l.c. | $219 |
|---|
| Travel and Lodging | $219 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| E.r. Squibb & Sons, L.l.c. Aug 29, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $219 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 7 industry-funded studies in 2025, from 5 companies. The companies reported $644,399 in research payments for these studies, mostly to the institutions running them.
- A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis
ModernaTX, Inc. · Active, not recruiting · NCT06592794 - Study Comparing Tapinarof Cream 1% To VTAMA (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis
Teva Pharmaceuticals USA, Inc. - A Phase 3b, Open-label, Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine As Part of Multimodal Therapy for Acute Pain After Laparoscopic Procedures of the Intraperitoneal or Retroperitoneal Cavi…
Vertex Pharmaceuticals Incorporated - UC P3: Double-Blind Treat Straight Through
F. Hoffmann-la Roche AG - A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1)
Genentech, Inc. - A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1)
F. Hoffmann-la Roche AG - UC P3: Double-Blind Treat Straight Through
Genentech, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.